Editas Medicine is a biotechnology company focused on developing therapies using gene editing technologies, particularly CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). The company aims to harness these advanced genetic editing techniques to treat a range of serious diseases by directly modifying genes at precise locations in the DNA. Editas Medicine works on research and development of treatments for genetic disorders and aims to bring innovative solutions to the field of medicine through its proprietary technologies.
In a shocking turn of events, Editas Medicine has announced a staggering 65% reduction in its workforce. This decision, impacting approximately 180 employees, comes as the biotech company decides to…